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O Perations on the tricuspid valve are usually per- formed in conjunction with treatment of some other 
valvular heart disease. Most commonly, the morphology 
of the tricuspid valve is dilation of the anulus secondary to 
pulmonary hypertension and right ventricular dilation 
associated with mitral or combined mitral and aortic 
valve disease. Anular dilation results in tricuspid valve 
regurgitation. The tricuspid valve leaflet issues are nor- 
mal or near normal so that repair of the tricuspid valve by 
anuloplasty techniques i nearly always possible and tri- 
cuspid valve replacement is sddom necessary. 
There are some pathologic processes that directly involve 
the tricuspid valve leaflet issues. Valve repair may not be 
possible, and replacement is required. Tricuspid valve en- 
docarditis, acute or subacute, may result in destruction of 
enough leaflet issue to require valve replacement. Endocar- 
ditis may be associated with pacemaker electrodes passed 
through the venous system adherent to the tricuspid valve 
and lodged in the right ventricle. Rheumatic heart disease 
may affect the tricuspid valve in conjtmction with other 
cardiac valves. 1The morphology is valve leaflet hickening 
and retraction with commissural fusion resulting in tricuspid 
valve stenosis and/or regurgitation. Carcinoid tumors pro- 
ducing serotonin (t-hydroxytryptamine) may destroy the tri- 
cuspid valve (and pulmonary valve) by cicatricial changes in 
leaflet issues causing tricuspid stenosis and regurgitation. 2 
Similar changes are seen in patients using phentermine-fen- 
floramine for appetite control. Tricuspid valve regurgitation, 
commonly associated with cardiac transplantation, 3 may be- 
come severe when associated with ruptured chordae tendi- 
nae from multiple right heart biopsies. There are some tri- 
cuspid valves affected by Ebstein's anomaly 40z that are so 
severely deformed that repair is either ineffective or impos- 
sible so that valve replacement is necessary. 
Methods of tricuspid valve replacement are detailed 
in this paper. 
leaflet Coronary sinus 
| Tricuspid valve replacement with mechanical or stented bioprosthetic valve. Tricuspid valve operations are 
performed via a standard midline sternotomy (complete or lower one half) or through an anterior thoracotomy on the 
right side. Cardiopulmonary b pass is established using two cannulae for venous uptake (inset figure) with oxygenated 
blood returned to a cannula placed in the ascending aorta. Tourniquets are secured around the vena cavae and cannulae 
to isolate the right atrium. Some operations lend well to continuous coronary perfusion, but most procedures are 
performed with the aorta occluded and the heart arrested by cold cardioplegic solution administered through a catheter 
in the coronary sinus. The tricuspid valve is excised beginning with the anterior leaflet, continuing around the posterior 
leaflet, and finally completing the excision over the septal eaflet. Nearly all or at least a considerable rim of the septal 
leaflet of the tricuspid valve should be preserved for attachment of the valve prosthesis. The appropriate size valve 
prosthesis i  selected based on measurements using valve anulus calibrators. 
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2 Pledger reinforced mattress utures are used to buttress and strengthen the tissue repair of the septal leaflet of the 
tricuspid valve. The stitches are placed through only leaflet tissue at the apex of the triangle of Koch to preserve the integrity 
and function of" the electrical conduction system. The rest of septal portion of the anulus is repaired by pledger-reinforced 
sutures passed around the anulus and leaflet remnant. The sutures are passed through the sewing ring of the prosthesis as the 
stitches are placed in the septal eaflet. 
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3 The prosthesis is attached to the rest of the anulus by continuous titches using 2/0 polypropylene suture material. The 
continuous uture is started as a pledget-reinforced mattress titch placed around the anulus anteriorly and brought hrough the 
sewing ring of the prosthesis. The prosthesis i placed in the right ventricle and the suture tightened to approximate he sewing ring 
of the prosthesis to the valve annulus. Stitches are placed from the anulus to the sewing ring of the prosthesis, worldng i  a clockwise 
fashion. Tension is n|aintained on the suture to approximatel the tissues firmly to the sewing ring of the prosthesis. Tension is 
released with each needle pass to facilitate xposure of the junction of ventricular myocardium and the anulus. 
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4 The stitches are continued to the junction of the anulus of the free wall with the septum. The remainder of the repair 
is done using the needle at the opposite end of the suture working in a counterclockwise fashion. The needle is passed from 
the tricuspid anulus to the sewing ring of the prosthesis, continuing to the commissure between septal and anterior leaflets. 
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5 The valve replacement is completed by tying sutures securely. An alternate technique involves using all interrupted 
pledgeted mattress titches when the tricuspid leaflet tissue and annulus is delicate and not as likely to hold secure with 
continuous uture technique. 
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6 Tricuspid valve replacentent with mitral valve homograft. The tricuspid valve is excised and the diameter of the anulus 
is measured as described above. A mitral valve homograft of the salne anular diameter is chosen. The homograft is 
cryopreserved and must be thawed, a process that takes approximately 20 minutes. The homograft is trimmed after thawing. 
The myocardium of the atrium and the ventricle is cut away from the anulus of the homograft, leaving just enough tissue to 
allow needle penetration without entering leaflet tissue The papillary muscles are shortened, leaving l0 mm of muscle below 
the chordal attachments. 
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7 Horizontal mattress stitches (2/0 braided polyester) for auuloplasty are placed through the annlus of the tricuspid valve except 
for the area occupied by the septal eaflet. These stitches are placed using both needles of a double needle suture passed from the 
right ventricle to the right atrium through the tricuspid valve anulus. The sutures are placed as the initial step of the operation, as 
it is easier than after the homograft is in place, exposure is enhanced, and this cml be performed uring the homograft thawing 
process. The anterior papillary muscle of the tricuspid valve is the only one suitable for attachment of the homograft papillary 
muscle. This papillary muscle supports all of the anterior and part of the posterior leaflets of the tricuspid valve, is usually of good 
size, and is continuous with the moderator band, which can provide additional support. 
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8 The mitral homograft is oriented with its anterior leaflet to the ventricular septum (septal eaflet area of the tricuspid 
valve). Orientation is maintained by placing a stitch of 4/0 polypropylene through the fibrous trigones at each end of the 
homograft anterior leaflet and passing the stitches through recipient ricuspid valve anulus or leaflet remnant at each end of 
the septal eaflet. 
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The anterior papillary muscle 
of the mitral homograft is positioned 
side-by-side to the anterior papillary 
muscle of the recipient tricuspid 
valve using a horizontal mattress 
stitch (inset figure). Firm attachment 
of the donor papillary muscle to the 
patient papillary muscle is accom- 
plished using 8 to 10 simple stitches of 
fine monofilament suture (5/0 Cardio- 
nylTM). A channel is made through the 
anterior wall of the right ventricle at 
an appropriate position to accommo- 
date the posterior papillary muscle of 
the homograft. The papillary muscle 
is pulled through the channel. It is 
secured to the epicardial surface of 
the right ventricle with multiple 
stitches of 5/0 Cardionyl TM suture. 
The homograft papillary muscle is 
also secured to the endocardial sur- 
face with multiple sutures. 
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][ O The anulus of the homograft is attached to the anulns of the recipient by continuous titches of 4/0 polypropylene 
sutures using the stitches previously placed in the fibrous trigones of the homograft. The stitches are placed around the anulus 
of the patient ricuspid valve and through the atrial remnant and anulus of the homograft. 
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Completed repair ....... .... 
][ ][ An anuloplasty band (Cosgrove Anuloplasty Band TM, Edwards LifeSciences, Anaheim, CA) or pericardial strip is used 
to support he tricuspid anulus in the portions occupied by the anterior and posterior leaflets. The septal portion is not 
supported. The anuloplasty band is attached to the tricuspid valve anutus by the previously placed mattress utures. The 
anuloplasty band is tied securely to the tricuspid anulus to complete the valve replacement. 
|~ 2 Photograph of tricuspid valve replacement with mitral valve homograft supported by Cosgrove Anuloplasty Band TM. 
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COMMENTS 
Replacement of the tricuspid valve is not often re- 
quired but there are some conditions in which the 
valve leaflet tissue is deficient or even destroyed to a 
degree that valve repair is not possible. Operations 
on the tricuspid valve are usually done concomi- 
tantly with operations on other cardiac valves. Iso- 
lated tricuspid valve replacement is a high risk pro- 
cedure with 30-day hospital mortality in the range of 
10% to 24%.6-a Complete heart block requiring pace- 
maker insertion as a complication of tricuspid valve 
replacement occurred in 28% of 32 patients reported 
by Do and associates. 9 Choice of replacement device 
is not conclusive. Significant advantage has not been 
demonstrated comparing mechanical prostheses to 
stent-mounted bioprostheses.7,8,1~ Tricuspid valve 
replacement with mitral valve homograft may offer 
some advantages in patients with tricuspid valve en- 
docarditis, ~2-~4 especially those infected with drug- 
resistant bacteria or fungus. 
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